Illumina Faces Uncertainties From China Ban, Research Slump, Morgan Stanley Says
In This Article:
Illumina's (ILMN) 2025 guidance cut reflects uncertainties due to faltering research demand, China's
Upgrade to read this MT Newswires article and get so much more.
A Silver or Gold subscription plan is required to access premium news articles.